» Articles » PMID: 35017313

Bacterial Biofilms Predominate in Both Acute and Chronic Human Lung Infections

Abstract

Background: A basic paradigm of human infection is that acute bacterial disease is caused by fast growing planktonic bacteria while chronic infections are caused by slow-growing, aggregated bacteria, a phenomenon known as a biofilm. For lung infections, this paradigm has been thought to be supported by observations of how bacteria proliferate in well-established growth media in the laboratory-the gold standard of microbiology.

Objective: To investigate the bacterial architecture in sputum from patients with acute and chronic lung infections.

Methods: Advanced imaging technology was used for quantification and direct comparison of infection types on fresh sputum samples, thereby directly testing the acute versus chronic paradigm.

Results: In this study, we compared the bacterial lifestyle (planktonic or biofilm), growth rate and inflammatory response of bacteria in freshly collected sputum (n=43) from patient groups presenting with acute or chronic lung infections. We found that both acute and chronic lung infections are dominated by biofilms (aggregates of bacteria within an extracellular matrix), although planktonic cells were observed in both sample types. Bacteria grew faster in sputum from acute infections, but these fast-growing bacteria were enriched in biofilms similar to the architecture thought to be reserved for chronic infections. Cellular inflammation in the lungs was also similar across patient groups, but systemic inflammatory markers were only elevated in acute infections.

Conclusions: Our findings indicate that the current paradigm of equating planktonic with acute and biofilm with chronic infection needs to be revisited as the difference lies primarily in metabolic rates, not bacterial architecture.

Citing Articles

Fungal biofilms in human health and disease.

Ramage G, Kean R, Rautemaa-Richardson R, Williams C, Lopez-Ribot J Nat Rev Microbiol. 2025; .

PMID: 39910237 DOI: 10.1038/s41579-025-01147-0.


Harnessing Cyclic di-GMP Signaling: A Strategic Approach to Combat Bacterial Biofilm-Associated Chronic Infections.

Snega Priya P, Meenatchi R, Pasupuleti M, Namasivayam S, Arockiaraj J Curr Microbiol. 2025; 82(3):118.

PMID: 39909925 DOI: 10.1007/s00284-025-04091-7.


CAM/TMA-DPH as a promising alternative to SYTO9/PI for cell viability assessment in bacterial biofilms.

Tchatchiashvili T, Jundzill M, Marquet M, Mirza K, Pletz M, Makarewicz O Front Cell Infect Microbiol. 2025; 14:1508016.

PMID: 39906213 PMC: 11790577. DOI: 10.3389/fcimb.2024.1508016.


Enhanced penetration and biofilm eradication by sophorolipid micelles encapsulating Honokiol: a comprehensive solution for biofilm-associated lung infections.

Lin S, Li X, Zhang W, Shu G, Tolker-Nielsen T, Li H J Nanobiotechnology. 2025; 23(1):76.

PMID: 39901249 PMC: 11792403. DOI: 10.1186/s12951-025-03144-0.


Fluoroquinolones and Biofilm: A Narrative Review.

Geremia N, Giovagnorio F, Colpani A, De Vito A, Botan A, Stroffolini G Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770514 PMC: 11679785. DOI: 10.3390/ph17121673.